Karyopharm Therapeutics Inc. · NASDAQ:KPTI
JPMorgan Chase & Co reported a 5.20% stake in Karyopharm Therapeutics Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Jul 16, 2025
JPMorgan Chase & Co reported a 5.20% stake in Karyopharm Therapeutics Inc., 450,436 shares, as a passive investor on Jun 30, 2025. Filed Jul 16, 2025 (Schedule 13G).
- Stake
- 5.20%
- Shares
- 450,436
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JPMORGAN CHASE & CO. | 5.20% | 450,436 |
Source
Related
- Karyopharm Therapeutics Inc.
- JPMorgan Chase & Co
- Karyopharm Therapeutics Inc. shareholders
- Schedule 13G/A · JPMorgan Chase & Co · Oct 17, 2025
- Form 4 · Abate Kristin · Oct 19, 2026
- Schedule 13G/A · Anders Hove · Oct 8, 2026
- Form 4 · Abate Kristin · Oct 2, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026